Target intelligence / Profile preview

Inflammatory enzyme (None.)

Target
None.
Molecular classification
Enzyme, Protease, Oxidoreductase, Hydrolase, Transferase
01

Overview

"Inflammatory enzymes" collectively refer to various enzymes that play key roles in initiating, propagating, regulating, or resolving inflammatory responses within tissues and organs.[3] These include but are not limited to proteases such as serine proteases and matrix metalloproteinases; oxidoreductases like cyclooxygenases; hydrolases including phospholipase A2; caspases involved in cell death pathways; deubiquitinylating enzymes modulating immune signaling cascades; among others.[2][7] They act through diverse mechanisms—such as activating pro-inflammatory cytokines,[1] degrading extracellular matrix components during tissue injury,[4] generating lipid mediators,[4] or controlling immune cell migration—and their dysregulation contributes significantly to acute and chronic inflammatory diseases.[2][4] For research or clinical purposes requiring structured information about drug targets, it is necessary to specify *which* particular inflammatory mediator/enzyme you mean—such as “cyclooxygenase‑2,” “matrix metalloproteinase‑9,” etc.—rather than using the generic category “inflammatory enzyme.”

Other names
Inflammation-related enzymesPro-inflammatory enzymesEnzymes involved in inflammation
02

Mechanism of action

Varies depending on the enzyme: Inhibition of prostaglandin synthesis via COX inhibition reduces inflammation. Protease inhibitors block tissue-degrading proteolytic activity. Modulation/inhibition of cytokine processing or release.

03

Biological functions

Immune response modulationSignal transduction during inflammationRegulation of cytokine activity and releaseTissue remodeling and repairCell death/apoptosis induction or inhibition
04

Disease associations

Inflammation (general)Autoimmune diseases (e.g., rheumatoid arthritis)Infectious diseasesCancer progression/metastasis via chronic inflammation pathwaysCardiovascular disease related to chronic inflammatory states
05

Safety considerations

Broad inhibition can lead to immunosuppression or impaired healingOff-target effects due to lack of specificity when inhibiting entire classes/families
06

Interacting drugs

Non-steroidal anti-inflammatory drugs (NSAIDs) – inhibit cyclooxygenases like COX‑1/COX‑2.

3 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Specific proteolytic fragments in blood/tissue samples

Beyond the preview

Go deeper on Inflammatory enzyme (None.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inflammatory enzyme (None.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call